Janux Therapeutics is a clinical-stage biotech company specializing in immunotherapies designed to trigger tumor-specific immune responses without harming healthy tissue. Utilizing its platform masking technology, Janux develops novel drug candidates that address the limitations of traditional T cell engagers. The company has earned recognition as a Great Place To Work Certificationā¢, highlighting its commitment to fostering an innovative and supportive work environment.
The Vice President of Global Medical Affairs will provide strategic and hands-on leadership for Janux Therapeutics, responsible for shaping scientific narrative, building external relationships, and ensuring high-quality, compliant medical engagement.
Janux Therapeutics is a clinical-stage biotech company specializing in immunotherapies designed to trigger tumor-specific immune responses without harming healthy tissue. Utilizing its platform masking technology, Janux develops novel drug candidates that address the limitations of traditional T cell engagers. The company has earned recognition as a Great Place To Work Certificationā¢, highlighting its commitment to fostering an innovative and supportive work environment.
Annexon Bioscience